Literature DB >> 6840857

Activation of macrophages by quinonyl-N-acetylmuramyl dipeptide.

I Saiki, Y Tokushima, K Nishimura, Y Yamamura, I Azuma.   

Abstract

The effect of 6-O-QS-10-N-acetylmuramyl-L-valyl-D-isoglutamine methyl ester (quinonyl-MDP-66) on various functions of macrophages was examined. Mouse peritoneal macrophages, when treated either in vitro or in vivo with quinonyl-MDP-66 suspended in phosphate-buffered saline, showed a capacity for cytolysis and cytostasis against tumor targets and released H2O2 in the presence of phorbol myristate acetate. The macrophages induced by quinonyl-MDP-66 also had both antibody-dependent cell-mediated cytotoxicity and phagocytic activity against erythroid targets. The fact that synthetic quinonyl-MDP-66 stimulates the macrophages to become more cytotoxic than do other MDP analogs suggests that the lipophilic residue (QS-10) in quinonyl-MDP-66 may be important for the development of this activity.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6840857      PMCID: PMC264899          DOI: 10.1128/iai.40.2.622-628.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  32 in total

1.  Antibody-dependent cytolysis of chicken erythrocytes by an in vitro-established line of mouse peritoneal macrophages.

Authors:  W S Walker; A Demus
Journal:  J Immunol       Date:  1975-02       Impact factor: 5.422

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Correlation of structure and adjuvant activity of N-acetyl muramyl-L-alanyl-D-isoglutamine (MDP), its derivatives and analogues. Anti-adjuvant and competition properties of stereoisomers.

Authors:  A Adam; M Devys; V Souvannavong; P Lefrancier; J Choay; E Lederer
Journal:  Biochem Biophys Res Commun       Date:  1976-09-07       Impact factor: 3.575

4.  Adjuvant activity of monomeric bacterial cell wall peptidoglycans.

Authors:  A Adam; R Ciorbaru; F Ellouz; J F Petit; E Lederer
Journal:  Biochem Biophys Res Commun       Date:  1974-02-04       Impact factor: 3.575

5.  Specific and nonspecific antitumor immunity. II. Macrophage-mediated nonspecific effector activity induced by BCG and similar agents.

Authors:  R N Germain; R M Williams; B Benacerraf
Journal:  J Natl Cancer Inst       Date:  1975-03       Impact factor: 13.506

6.  Adjuvant activity of synthetic 6-O-"mycoloyl"-N-acetylmuramyl-L-alanyl-D-isoglutamine and related compounds.

Authors:  I Azuma; K Sugimura; M Yamawaki; M Uemiya; S Kusumoto; S Okada; T Shiba; Y Yamamura
Journal:  Infect Immun       Date:  1978-06       Impact factor: 3.441

7.  Enhancement of nonspecific immunity to Klebsiella pneumoniae infection by a synthetic immunoadjuvant (N-acetylmuramyl-L-alanyl-D-isoglutamine) and several analogs.

Authors:  L Chedid; M Parant; F Parant; P Lefrancher; J Choay; E Lederer
Journal:  Proc Natl Acad Sci U S A       Date:  1977-05       Impact factor: 11.205

8.  Comparison between macrophage activation and enhancement of nonspecific resistance to tumors by mycobacterial immunoadjuvants.

Authors:  D Juy; L Chedid
Journal:  Proc Natl Acad Sci U S A       Date:  1975-10       Impact factor: 11.205

9.  Possible evidence for antibody-dependent macrophage-mediated cytotoxicity directed against murine adenocarcinoma cells in vivo.

Authors:  J S Haskill; J W Fett
Journal:  J Immunol       Date:  1976-11       Impact factor: 5.422

10.  Immunoadjuvant activities of synthetic N-acetyl-muramyl-peptides or -amino acids.

Authors:  S Kotani; Y Watanabe; F Kinoshita; T Shimono; I Morisaki
Journal:  Biken J       Date:  1975-06
View more
  1 in total

1.  Activation of mouse peritoneal adherent cells with N-acyl muramyl dipeptide derivatives.

Authors:  K Nishimura; H Okumura; I Saiki; H Okuyama; I Azuma
Journal:  Infect Immun       Date:  1985-03       Impact factor: 3.441

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.